Phenothiazine compounds for treating mild cognitive impairment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9211294
SERIAL NO

12665608

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to methods and materials based on diaminophenothiazines for use in the treatment of Mild Cognitive Impairment (MCI).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WISTA LABORATORIES LTD25 BUKIT BATOK CRESCENT THE ELITIST #06-13 SINGAPORE 658066

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deiana, Serena Aberdeen, GB 1 6
Goatman, Elizabeth Anne Aberdeen, GB 1 6
Harbaran, Dominic Venay Aberdeen, GB 1 6
Murray, Alison Dorothy Aberdeen, GB 2 18
Riedel, Gernot Aberdeen, GB 15 44
Staff, Roger Todd Aberdeen, GB 3 18
Wischik, Claude Michel Aberdeen, GB 68 401
Wischik, Damon Jude London, GB 13 69

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00